BAT CEO Denies Moving Listing to New York

BAT by 2FIRSTS.ai
Mar.18.2024
BAT CEO Denies Moving Listing to New York
British American Tobacco CEO Tadeu Marroco denies plans to move the company's listing from London to New York.

According to a report from the UK's Financial Times, Tadeu Marroco, the CEO of British American Tobacco, has denied the idea of moving the company's listing from London to New York, calling it a "distraction." Previously, the top ten shareholders who were pushing for this change have sold their stakes in the tobacco company.

 

Maroko told the Financial Times that the change of listing venue "will cause a lot of disruption internally," and he is "uncertain if its benefits are as obvious as some people suggest.

 

Last year, Rajiv Jain, Chairman and Chief Investment Officer of the US investment group GQG Partners with $105 billion in assets, urged British American Tobacco to switch its primary listing and clashed with management over the decision to suspend the company's stock buyback program.

 

According to two sources familiar with the matter, GQG sold its 4% stake in British American Tobacco last July because they refused to move and leverage the larger pool of capital in the US, particularly in tobacco stocks. In Europe, an investment environment dominated by ESG considerations means that almost no capital is willing to invest in the tobacco industry.

 

When asked whether he would consider changing the listing location during his tenure, Maroko said, "I believe we should not focus on this issue during this period.

 

He added that there are "many other things" he needs to do, including income in the United States and new products. "There is no indication that... going to the United States is a certainty."

 

He acknowledged that the London capital market is working hard to attract and retain listed companies, but he mentioned the advantages of staying in the UK for investors. Companies that have already moved their main listing venues to the United States include building materials group CRH, packaging company Smurfit Kappa, and gambling group Flutter.

 

Marroco stated, "If you hold shares in a British (listed) company and are overseas, you do not have to pay withholding tax on dividends, unlike in the United States."

 

He said, "I hope that within 10 years, we no longer have to have these discussions." "The reason why there is such a high level of emotions today is due to the frustration caused by some people leaving."

 

For investors, the main reason they are attracted to invest in tobacco stocks is the capital return from dividends and stock buybacks. One of the biggest active investors in British American Tobacco is Spring Mountain Investments, which is an investment vehicle of Kenneth Dart, a billionaire from the Cayman Islands and one of the world's largest foam cup manufacturers.

 

British American Tobacco announced this month that it will use the proceeds from the sale of a portion of its shares in Indian conglomerate ITC for £1.7 billion to restart its stock buyback program, starting with a £700 million buyback this year.

 

Marroco stated, "For me, the most important thing is the restart of repurchases, which should be a consistent feature of our capital allocation."

 

British American Tobacco is facing challenges in reversing the decline in tobacco sales in the United States, its largest market. This is due to people turning to cheaper brands and alternative tobacco products, in which the company is lagging behind the highly successful PMI, whose IQOS heated tobacco product has been very successful.

 

British American Tobacco's goal is to have 50% of its revenue come from alternative products by 2035, such as its Vuse e-cigarette and Glo heated tobacco devices.

 

Marroco acknowledged that English-American Tobacco "started late in the heated tobacco products field," but he stated that due to the company's market share in the US, they have the ability to catch up. "We have a large business in the US that can be used to sell (new products)."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
Oregon Supreme Court to Hear Case Challenging Restrictions on E-Cigarette Descriptions
The Oregon Supreme Court prepares to review a case challenging restrictions on e-cigarette product descriptions, impacting small businesses and consumers.
Sep.22 by 2FIRSTS.ai
After Singapore strengthened e-cigarette regulations, the price of black market products increased by three times
After Singapore strengthened e-cigarette regulations, the price of black market products increased by three times
Malaysian merchants in Johor Bahru report that up to 95% of their e-cigarette customers are from Singapore. Since Singapore intensified penalties from September 1st, some stores have provided discreet packaging or smuggling tips, though most have stopped cross-border deliveries. Black market e-cigarette prices in Johor Bahru have tripled, and shipping fees across the border have risen sharply.
Sep.11 by 2FIRSTS.ai
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
A new study shows that flavored e-cigarettes, even without nicotine, can interfere with embryo implantation and placental development, increasing the risks of miscarriage and fetal growth restriction, underscoring their potential threat to pregnancy safety.
Sep.01 by 2FIRSTS.ai
London police crackdown on drug-laced e-cigarettes: Over 2,000 poisoning charges expected in 2024-2025
London police crackdown on drug-laced e-cigarettes: Over 2,000 poisoning charges expected in 2024-2025
London police announced a crackdown on drug-tainted e-cigarettes. The operation stemmed from an incident in the southeast of the capital where e-cigarettes were laced with "cannabis-like products," leading to the hospitalization of a 14-year-old. Data shows that between March 2024 and March 2025, London police received over 2,000 allegations of drug-tainted e-cigarettes. Of the victims in August 2025, 66% were women, a disproportionately high proportion.
Sep.26 by 2FIRSTS.ai
Henrico County, Virginia Cracks Down on Illegal Vape Shops, Citing Threats to Public Health and Youth Safety
Henrico County, Virginia Cracks Down on Illegal Vape Shops, Citing Threats to Public Health and Youth Safety
Officials in Henrico County, Virginia, warn that some vape shops are selling products to minors without checking IDs and using fruit flavors to entice young people. Although the law requires shops to keep their distance from schools and similar locations and to hold permits, some operators evade the rules by posing as convenience stores. Local officials say vape shops have become “overrun,” threatening community health and youth safety.
Sep.02 by 2FIRSTS.ai